• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.HIV 感染儿童对四价 HPV 疫苗的记忆 B 细胞和 T 细胞应答的持久性。
AIDS. 2018 Apr 24;32(7):851-860. doi: 10.1097/QAD.0000000000001773.
2
Relationship between Humoral Immune Responses against HPV16, HPV18, HPV31 and HPV45 in 12-15 Year Old Girls Receiving Cervarix® or Gardasil® Vaccine.接种卉妍康®或加卫苗®疫苗的12至15岁女孩针对人乳头瘤病毒16型、18型、31型和45型的体液免疫反应之间的关系
PLoS One. 2015 Oct 23;10(10):e0140926. doi: 10.1371/journal.pone.0140926. eCollection 2015.
3
Long-term HPV-specific immune response after one versus two and three doses of bivalent HPV vaccination in Dutch girls.荷兰女孩接种二价 HPV 疫苗一剂、两剂和三剂后 HPV 特异性免疫应答的长期随访。
Vaccine. 2019 Nov 20;37(49):7280-7288. doi: 10.1016/j.vaccine.2019.09.066. Epub 2019 Sep 28.
4
Safety and immunogenicity of the quadrivalent human papillomavirus (qHPV) vaccine in HIV-positive Spanish men who have sex with men (MSM).四价人乳头瘤病毒(qHPV)疫苗在西班牙男男性行为者(MSM)HIV阳性人群中的安全性和免疫原性。
AIDS Res Ther. 2017 Jul 18;14(1):34. doi: 10.1186/s12981-017-0160-0.
5
Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine.在感染HIV的儿童中四价人乳头瘤病毒疫苗接种后特定类型免疫的四年持续性:第四剂疫苗的效果
Vaccine. 2017 Mar 23;35(13):1712-1720. doi: 10.1016/j.vaccine.2017.02.021. Epub 2017 Feb 24.
6
Safety and immunogenicity of the HPV-16/18 AS04-adjuvanted vaccine in HIV-positive women in South Africa: a partially-blind randomised placebo-controlled study.南非 HIV 阳性女性中 HPV-16/18 AS04 佐剂疫苗的安全性和免疫原性:一项部分盲随机安慰剂对照研究。
Vaccine. 2013 Nov 19;31(48):5745-53. doi: 10.1016/j.vaccine.2013.09.032. Epub 2013 Oct 1.
7
Induction of immune memory following administration of a prophylactic quadrivalent human papillomavirus (HPV) types 6/11/16/18 L1 virus-like particle (VLP) vaccine.预防性四价人乳头瘤病毒(HPV)6/11/16/18型L1病毒样颗粒(VLP)疫苗接种后免疫记忆的诱导
Vaccine. 2007 Jun 21;25(26):4931-9. doi: 10.1016/j.vaccine.2007.03.049. Epub 2007 Apr 20.
8
Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study.双价人乳头瘤病毒疫苗在幼年特发性关节炎女性患者中的免疫原性和安全性:一项前瞻性对照观察队列研究。
Ann Rheum Dis. 2014 Aug;73(8):1500-7. doi: 10.1136/annrheumdis-2013-203429. Epub 2013 May 30.
9
Humoral, mucosal, and cell-mediated immunity against vaccine and nonvaccine genotypes after administration of quadrivalent human papillomavirus vaccine to HIV-infected children.感染 HIV 的儿童接种四价人乳头瘤病毒疫苗后针对疫苗和非疫苗基因型的体液、黏膜和细胞介导免疫。
J Infect Dis. 2012 Oct;206(8):1309-18. doi: 10.1093/infdis/jis489. Epub 2012 Aug 2.
10
A Single Human Papillomavirus Vaccine Dose Improves B Cell Memory in Previously Infected Subjects.单剂量人乳头瘤病毒疫苗可改善既往感染者的B细胞记忆。
EBioMedicine. 2016 Aug;10:55-64. doi: 10.1016/j.ebiom.2016.06.042. Epub 2016 Jun 29.

引用本文的文献

1
Understanding human papillomavirus vaccine response and efficacy in people living with HIV: A systematic mixed studies review and meta-analysis.了解人类乳头瘤病毒疫苗在艾滋病毒感染者中的反应和疗效:一项系统的混合研究综述和荟萃分析。
PLOS Glob Public Health. 2024 Dec 20;4(12):e0003931. doi: 10.1371/journal.pgph.0003931. eCollection 2024.
2
Immunogenicity and Efficacy of Vaccination in People Living with Human Immunodeficiency Virus.人类免疫缺陷病毒感染者接种疫苗的免疫原性和疗效
Viruses. 2023 Aug 30;15(9):1844. doi: 10.3390/v15091844.
3
State-of-the-Science of human papillomavirus vaccination in women with human immunodeficiency Virus: Summary of a scientific workshop.人类免疫缺陷病毒感染女性的人乳头瘤病毒疫苗接种科学现状:科学研讨会总结
Prev Med Rep. 2023 Jul 19;35:102331. doi: 10.1016/j.pmedr.2023.102331. eCollection 2023 Oct.
4
Efficacy and Durability of Immune Response after Receipt of HPV Vaccines in People Living with HIV.HIV感染者接种HPV疫苗后的免疫反应效力和持久性
Vaccines (Basel). 2023 Jun 5;11(6):1067. doi: 10.3390/vaccines11061067.
5
Long-term human papillomavirus vaccination effectiveness and immunity in Rwandan women living with and without HIV: a study protocol.长期人乳头瘤病毒疫苗接种效果和免疫在卢旺达妇女与艾滋病毒感染者和非感染者:研究方案。
BMJ Open. 2022 Aug 25;12(8):e061650. doi: 10.1136/bmjopen-2022-061650.
6
Immunogenicity, safety, and efficacy of the HPV vaccines among people living with HIV: A systematic review and meta-analysis.人免疫缺陷病毒感染者中HPV疫苗的免疫原性、安全性和有效性:一项系统评价与荟萃分析
EClinicalMedicine. 2022 Aug 3;52:101585. doi: 10.1016/j.eclinm.2022.101585. eCollection 2022 Oct.
7
Cervical cancer prevention and control in women living with human immunodeficiency virus.女性人类免疫缺陷病毒感染者的宫颈癌预防与控制。
CA Cancer J Clin. 2021 Nov;71(6):505-526. doi: 10.3322/caac.21696. Epub 2021 Sep 9.
8
A systematic review of immunogenicity, clinical efficacy and safety of human papillomavirus vaccines in people living with the human immunodeficiency virus.一项关于人类免疫缺陷病毒感染者中 HPV 疫苗的免疫原性、临床疗效和安全性的系统评价。
Hum Vaccin Immunother. 2020;16(2):426-435. doi: 10.1080/21645515.2019.1656481. Epub 2019 Sep 20.
9
HPV vaccination in HIV infection.人类免疫缺陷病毒感染中的人乳头瘤病毒疫苗接种
Papillomavirus Res. 2019 Dec;8:100174. doi: 10.1016/j.pvr.2019.100174. Epub 2019 Jun 25.
10
A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women.肯尼亚人免疫缺陷病毒感染和未感染妇女中与致癌性人乳头瘤病毒检测相关因素的横断面分析。
BMC Infect Dis. 2019 Apr 27;19(1):352. doi: 10.1186/s12879-019-3982-7.

本文引用的文献

1
HPV vaccines - A review of the first decade.HPV 疫苗——首个十年的回顾。
Gynecol Oncol. 2017 Jul;146(1):196-204. doi: 10.1016/j.ygyno.2017.04.004. Epub 2017 Apr 22.
2
Brief Report: Antibody Responses to Quadrivalent HPV Vaccination in HIV-Infected Young Women as Measured by Total IgG and Competitive Luminex Immunoassay.简短报告:通过总IgG和竞争性Luminex免疫测定法检测HIV感染年轻女性对四价HPV疫苗的抗体反应
J Acquir Immune Defic Syndr. 2017 Jun 1;75(2):241-245. doi: 10.1097/QAI.0000000000001355.
3
Four-year persistence of type-specific immunity after quadrivalent human papillomavirus vaccination in HIV-infected children: Effect of a fourth dose of vaccine.在感染HIV的儿童中四价人乳头瘤病毒疫苗接种后特定类型免疫的四年持续性:第四剂疫苗的效果
Vaccine. 2017 Mar 23;35(13):1712-1720. doi: 10.1016/j.vaccine.2017.02.021. Epub 2017 Feb 24.
4
Substantial Decline in Vaccine-Type Human Papillomavirus (HPV) Among Vaccinated Young Women During the First 8 Years After HPV Vaccine Introduction in a Community.在某社区引入人乳头瘤病毒(HPV)疫苗后的头8年里,接种疫苗的年轻女性中疫苗型人乳头瘤病毒(HPV)大幅下降。
Clin Infect Dis. 2016 Nov 15;63(10):1281-1287. doi: 10.1093/cid/ciw533. Epub 2016 Sep 20.
5
HIV viral suppression results in higher antibody responses in HIV-positive women vaccinated with the quadrivalent human papillomavirus vaccine.在接种四价人乳头瘤病毒疫苗的HIV阳性女性中,HIV病毒抑制可导致更高的抗体反应。
Vaccine. 2016 Sep 14;34(40):4799-806. doi: 10.1016/j.vaccine.2016.08.016. Epub 2016 Aug 17.
6
Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.人乳头瘤病毒阳性头颈部鳞状细胞癌的流行病学
J Clin Oncol. 2015 Oct 10;33(29):3235-42. doi: 10.1200/JCO.2015.61.6995. Epub 2015 Sep 8.
7
Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012.2008 - 2012年美国人群中人类乳头瘤病毒疫苗监测效果,新发感染项目
Emerg Infect Dis. 2015 Sep;21(9):1557-61. doi: 10.3201/eid2109.141841.
8
Evaluation of the Long-Term Anti-Human Papillomavirus 6 (HPV6), 11, 16, and 18 Immune Responses Generated by the Quadrivalent HPV Vaccine.四价人乳头瘤病毒疫苗产生的长期抗人乳头瘤病毒6型(HPV6)、11型、16型和18型免疫反应的评估
Clin Vaccine Immunol. 2015 Aug;22(8):943-8. doi: 10.1128/CVI.00133-15. Epub 2015 Jun 17.
9
Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: follow-up through Month 48 in a Phase III randomized study.人乳头瘤病毒(HPV)-16/18 AS04佐剂疫苗与HPV-6/11/16/18疫苗在18至45岁健康女性中的体液和细胞免疫原性及安全性比较:一项III期随机研究中至第48个月的随访
Hum Vaccin Immunother. 2014;10(12):3455-65. doi: 10.4161/hv.36117.
10
Characteristics of memory B cells elicited by a highly efficacious HPV vaccine in subjects with no pre-existing immunity.在无预先存在免疫力的受试者中,一种高效HPV疫苗引发的记忆B细胞的特征。
PLoS Pathog. 2014 Oct 16;10(10):e1004461. doi: 10.1371/journal.ppat.1004461. eCollection 2014 Oct.

HIV 感染儿童对四价 HPV 疫苗的记忆 B 细胞和 T 细胞应答的持久性。

Persistence of memory B-cell and T-cell responses to the quadrivalent HPV vaccine in HIV-infected children.

机构信息

Section of Pediatric Infectious Diseases, Departments of Pediatrics and Medicine, and Pathology, University of Colorado Anschutz Medical Campus, Aurora, Colorado.

Center for Biostatistics in AIDS Research, Harvard School of Public Health, Boston, Massachusetts.

出版信息

AIDS. 2018 Apr 24;32(7):851-860. doi: 10.1097/QAD.0000000000001773.

DOI:10.1097/QAD.0000000000001773
PMID:29424778
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5869173/
Abstract

OBJECTIVE

To determine the magnitude and persistence of quadrivalent human papillomavirus (HPV)16 and HPV18 B-cell and T-cell memory after three or four doses of quadrivalent HPV vaccine (QHPV) in HIV-infected children.

METHODS

Seventy-four HIV-infected children immunized with four doses and 23 with three doses of QHPV had HPV16 and HPV18 IgG B-cell and IFNγ and IL2 T-cell ELISPOT performed at 2, 3.5 and 4-5 years after the last dose.

RESULTS

HPV16 and HPV18 T-cell responses were similar in both treatment groups, with higher responses to HPV16 vs. HPV18. These HPV T-cell responses correlated with HIV disease characteristics at the study visits. Global T-cell function declined over time as measured by nonspecific mitogenic stimulation. B-cell memory was similar across treatment groups and HPV genotypes. There was a decline in HPV-specific B-cell memory over time that reached statistical significance for HPV16 in the four-dose group.

CONCLUSION

B-cell and T-cell memory did not significantly differ after either three or four doses of QHPV in HIV-infected children. The clinical consequences of decreasing global T-cell function and HPV B-cell memory over time in HIV-infected children requires further investigation.

摘要

目的

确定在感染 HIV 的儿童中接种四价人乳头瘤病毒(HPV)疫苗(QHPV)三剂或四剂后,HPV16 和 HPV18 B 细胞和 T 细胞记忆的程度和持久性。

方法

74 名接受四剂 QHPV 免疫的 HIV 感染儿童和 23 名接受三剂 QHPV 免疫的儿童在最后一剂后 2、3.5 和 4-5 年进行了 HPV16 和 HPV18 IgG B 细胞和 IFNγ 和 IL2 T 细胞 ELISPOT。

结果

两组治疗组的 HPV16 和 HPV18 T 细胞反应相似,HPV16 对 HPV18 的反应更高。这些 HPV T 细胞反应与研究期间的 HIV 疾病特征相关。非特异性有丝分裂刺激测量的全球 T 细胞功能随时间下降。B 细胞记忆在各组和 HPV 基因型之间相似。随着时间的推移,HPV 特异性 B 细胞记忆下降,四剂组 HPV16 达到统计学意义。

结论

在感染 HIV 的儿童中,接种三剂或四剂 QHPV 后,B 细胞和 T 细胞记忆没有显著差异。随着时间的推移,HIV 感染儿童的全球 T 细胞功能和 HPV B 细胞记忆下降的临床后果需要进一步研究。